What is the CVR number of ORIFARM GENERICS A/S?

ORIFARM GENERICS A/S is registered with CVR / Virk under CVR 25674030.

What is the revenue of ORIFARM GENERICS A/S?

ORIFARM GENERICS A/S reported revenue of DKK 2,5B in 2025.

ORIFARM GENERICS A/S employs 281 people as of the latest annual report.

Thomas Brandhof is the CEO of ORIFARM GENERICS A/S, in role since 2025.

Hans Carl Bøgh-Sørensen chairs the board of ORIFARM GENERICS A/S, in role since 2011.

ORIFARM GENERICS A/S's registered address is Energivej 15.

A/SActiveAdvertising protection

CVR 25674030Energivej 15, 5260 Odense SWholesale of pharmaceutical and medical goods· NACE 4646Est. 2000 · 25 years old281 employees

Actively employed in the business

Name	Role	Member since
Current (1)
TB Thomas Brandhof Chief Executive Officer	Chief Executive Officer	2025
Former (5)
KH Karsten Haumann Chief Executive Officer	Chief Executive Officer	2018 – 2025
UE Ulrik Ernst Rasmussen Chief Executive Officer	Chief Executive Officer	2013 – 2018
JK Jan Kruse Hansen Chief Executive Officer	Chief Executive Officer	2009 – 2012
ES Erik Sandberg Chief Executive Officer	Chief Executive Officer	2012 – 2013
PA Peter Andreas Stakemann Management	Management	2000 – 2001

Non-executive oversight

Name	Role	Member since
Current (4)
HC Hans Carl Bøgh-Sørensen Chairman	Chairman	2011
MF Mads Fink Eriksen Board of Directors	Board of Directors	2025
BB Birgitte Bøgh-Sørensen Board of Directors	Board of Directors	2011
NL Nicki Lund Kristensen Board of Directors	Board of Directors	2025
Former (9)
AH Annemette Heller Board of Directors	Board of Directors	2000 – 2001
PM Per Munk Laustsen Board of Directors	Board of Directors	2003 – 2008
OI Ole Ibsen Board of Directors	Board of Directors	2008 – 2012
KM Kim Madsen Chairman	Chairman	2000 – 2001
HC Hans Christian Eberhard Groth Teisen Board of Directors	Board of Directors	2012 – 2014
DD Dennis Dencher Board of Directors	Board of Directors	2022 – 2024
NT Niels Thorborg Board of Directors	Board of Directors	2001 – 2003
UK Ulrik Kronborg Markussen Board of Directors	Board of Directors	2003 – 2009
OM Ole Michael Friis Chairman	Chairman	2001 – 2003

As of last annual report

Shareholder	Type	Ownership	Votes	Since
ORIFARM GENERICS HOLDING A/S	Company	100%	100%	2004

Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.